These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


218 related items for PubMed ID: 7121665

  • 21. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T, Taguchi H.
    Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Urine calcium/citrate ratio in children with hypercalciuric stones.
    Srivastava T, Winston MJ, Auron A, Alon US.
    Pediatr Res; 2009 Jul; 66(1):85-90. PubMed ID: 19287339
    [Abstract] [Full Text] [Related]

  • 25. Risk factors for low urinary citrate in calcium nephrolithiasis: low vegetable fibre intake and low urine volume to be added to the list.
    Hess B, Michel R, Takkinen R, Ackermann D, Jaeger P.
    Nephrol Dial Transplant; 1994 Jul; 9(6):642-9. PubMed ID: 7970090
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effect of potential renal acid load of foods on calcium metabolism of renal calcium stone formers.
    Trinchieri A, Zanetti G, Currò A, Lizzano R.
    Eur Urol; 2001 Jan; 39 Suppl 2():33-6; discussion 36-7. PubMed ID: 11223695
    [Abstract] [Full Text] [Related]

  • 28. Metabolic and glucose load studies in uric acid, oxalic and hyperparathyroid stone formers.
    Schwille PO, Scholz D, Hagemann G, Sigel A.
    Adv Exp Med Biol; 1974 Jan; 41():485-94. PubMed ID: 4832572
    [No Abstract] [Full Text] [Related]

  • 29. [Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers].
    Iguchi M, Ikegami M, Kiwamoto H, Umekawa T, Ishikawa Y, Kohri K, Kurita T.
    Hinyokika Kiyo; 1993 May; 39(5):425-31. PubMed ID: 8322624
    [Abstract] [Full Text] [Related]

  • 30. Contribution to therapeutic decisions of ratios, absolute values and other measures of calcium, magnesium, urate or oxalate balance in stone formers.
    Drach GW.
    J Urol; 1976 Sep; 116(3):338-40. PubMed ID: 957503
    [Abstract] [Full Text] [Related]

  • 31. Idiopathic recurrent calcium urolithiasis (IRCU): an acid meal challenge uncovers inappropriate pH of postprandial, fasting and daily urine: a cross-sectional study of male patients providing insight into post- and pre-load urinary stone substances, crystallization risk, presence of stones, renal transport and systemic metabolic factors.
    Schwille PO, Wipplinger J.
    Eur J Med Res; 2008 Jul 28; 13(7):332-42. PubMed ID: 18700191
    [Abstract] [Full Text] [Related]

  • 32. Frequency of renal phosphate leak among patients with calcium nephrolithiasis.
    Prié D, Ravery V, Boccon-Gibod L, Friedlander G.
    Kidney Int; 2001 Jul 28; 60(1):272-6. PubMed ID: 11422761
    [Abstract] [Full Text] [Related]

  • 33. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid in the management of hypercalciuric stone formers.
    Ortiz-Alvarado O, Miyaoka R, Kriedberg C, Leavitt DA, Moeding A, Stessman M, Monga M.
    Urology; 2012 Feb 28; 79(2):282-6. PubMed ID: 22000931
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Phosphate metabolism in renal stone formers. (II): Relation to renal tubular functions and calcium metabolism.
    Wikström B, Backman U, Danielson BG, Fellström B, Johansson G, Ljunghall S, Wide L.
    Scand J Urol Nephrol Suppl; 1981 Feb 28; 61():II:1-26. PubMed ID: 6274002
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Twenty four hours urine and serum biochemical parameters in patients with urolithiasis.
    Jawalekar S, Surve VT, Bhutey AK.
    Nepal Med Coll J; 2010 Mar 28; 12(1):5-7. PubMed ID: 20677601
    [Abstract] [Full Text] [Related]

  • 38. [Clinical studies on recurrence of urolithiasis. (2) Hypercalciuria and recurrence of urolithiasis].
    Murayama T, Taguchi H.
    Hinyokika Kiyo; 1987 Nov 28; 33(11):1766-71. PubMed ID: 3445858
    [Abstract] [Full Text] [Related]

  • 39. Contributory metabolic factors in the development of nephrolithiasis in patients with medullary sponge kidney.
    Yagisawa T, Kobayashi C, Hayashi T, Yoshida A, Toma H.
    Am J Kidney Dis; 2001 Jun 28; 37(6):1140-3. PubMed ID: 11382681
    [Abstract] [Full Text] [Related]

  • 40. Chemical factors important to calcium nephrolithiasis: evidence for impaired hydroxycarboxylic acid absorption causing hyperoxaluria.
    Cowley DM, McWhinney BC, Brown JM, Chalmers AH.
    Clin Chem; 1987 Feb 28; 33(2 Pt 1):243-7. PubMed ID: 3802507
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.